Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia

av Xie, Chengying, He, Ye, Zhen, Mingyue, Wang, Yulan, Xu, Yongping, Lou, Liguang
I publikationen Cancer Sci (2017)